Skip to main content

Table 3 Adverse events

From: Outcomes and prognostic factors in canine T cell lymphoma treated with lomustine, vincristine, cyclophosphamide, and prednisone chemotherapy

 

VCOG-CTCAE v2 Grade

Total adverse events (n = 98)

1

2

3

4

Vincristine

Gastrointestinal

7

10

4

0

 

Neutropenia

22

3

3

3

Cyclophosphamide

Gastrointestinal

8

1

0

0

 

Neutropenia

9

1

0

1

 

Hemorrhagic cystitis

0

0

0

0

Lomustine

Gastrointestinal

2

2

2

0

 

Neutropenia

8

2

4

3